Filter
4944
Filtered Results: 4944
Text search:
drug
quality
Featured
Recommendations
444
New Publications
1409
Language
Document type
No document type
3097
Studies & Reports
715
Guidelines
619
Manuals
208
Strategic & Response Plan
143
Fact sheets
63
Training Material
52
Situation Updates
17
Infographics
14
Resource Platforms
9
Brochures
4
Online Courses
2
App
1
Countries / Regions
India
311
Kenya
162
Global
149
Ethiopia
123
South Africa
123
Uganda
120
Western and Central Europe
105
Nigeria
103
Nepal
102
Tanzania
88
Malawi
87
Sierra Leone
85
Liberia
83
Zambia
79
Ghana
73
Bangladesh
69
Africa
69
Myanmar / Burma
68
Latin America and the Carribbean
62
Rwanda
60
Namibia
49
Eastern Europe
47
Ukraine
46
Philippines
41
Cambodia
40
Zimbabwe
38
Lesotho
33
Asia
33
South–East Asia Region
32
Botswana
29
Indonesia
25
Russia
25
Congo, Democratic Republic of
20
Syria
20
Mozambique
20
Eswatini/ Swaziland
19
Brazil
18
Burkina Faso
17
Senegal
17
East and Southern Africa
15
USA
14
West and Central Africa
13
Eastern Europe and Central Asia
13
Haiti
12
Cameroon
11
South Sudan
11
Germany
11
Middle East and North Africa
11
Tajikistan
11
Georgia
11
Pakistan
10
Colombia
10
Albania
10
Thailand
9
Vietnam
9
Afghanistan
8
Sudan
8
Guinea
7
Venezuela
7
Laos
7
North Macedonia
6
Western Pacific Region
6
Moldova
6
Iraq
5
Lebanon
5
China
5
Benin
5
Chile
5
Paraguay
5
Armenia
5
Jordan
4
Argentina
4
Peru
4
Sri Lanka
4
Jamaica
4
United Kingdom
4
Turkey
3
El Salvador
3
Bolivia
3
Mexico
3
Bhutan
3
Southern Africa
3
Kyrgyzstan
3
North America
3
Morocco
2
Saudi Arabia
2
Somalia
2
Papua New Guinea
2
Central African Republic
2
Hungary
2
Libya
2
Yemen
2
Fiji
2
Poland
2
Palestine
2
Mongolia
2
Timor Leste/ East Timor
2
Estonia
2
Iran
2
Kazakhstan
2
Belgium
2
Portugal
2
Belarus
2
Mali
1
Guinea-Bissau
1
Gambia
1
Ireland
1
Singapore
1
Switzerland
1
Serbia
1
Honduras
1
Greece
1
Angola
1
Madagascar
1
Canada
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Uzbekistan
1
Australia
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
2028
Clinical Guidelines
434
Public Health
254
Women & Child Health
196
Key Resources
100
Capacity Building
68
Pharmacy & Technologies
68
Annual Report MEDBOX
1
Toolboxes
HIV
575
Mental Health
470
TB
441
AMR
266
Pharmacy
182
COVID-19
173
NTDs
130
NCDs
110
Caregiver
104
Rapid Response
73
Planetary Health
65
Ebola
59
Refugee
58
Disability
57
Conflict
53
Global Health Education
51
Health Financing Toolbox
27
Natural Hazards
21
Polio
17
Cholera
14
Social Ethics
14
Zika
11
Specific Hazards
10
Health Financing
1
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
More than 40% of the world population is 24 years old or younger, the vast majority of whom live in low- and lower middle–income countries. Globally, a quarter of disability-adjusted life years (DALYs) for mental disorders and substance abuse is borne by this age group and about 75% of mental diso...
As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the global HIV/AIDS epidemic. Financing a sufficient and sustained response to the epidemic has emerged as one of t...
Nutrition data and information systems (ND&IS) are critical to guide the prioritisation, collection, analysis and
dissemination of nutrition data in countries. However, there is limited guidance for countries regarding how to invest
in their ND&IS and little is known about current financing alloca...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
A major problem facing the world is how to build peace following the ravages of increasingly protracted armed conflict. Armed conflicts leave behind shattered, divided societies that are at risk of repeating cycles of violence, and therefore need concerted peacebuilding efforts. Conflicts also take ...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns...
Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access to effective mental health treatments and progression towards universal health coverage.
This manual provides managers and others responsible for plan...
